Scherber RM, Mesa RA. Managing myelofibrosis (MF) that “blasts” through: advancements in the treatment of relapsed/refractory and blast-phase MF. Hematology Am Soc Hematol Educ Program. 2018;2018:118-126.

doi:10.1182/hematology.201900100

Page 118: The author affiliations are incorrect. The author and affiliation lines should read as shown below. The error has been corrected in the online version.

Robyn M. Scherber and Ruben A. Mesa

UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX

2019

American Society of Hematology

Scherber RM, Mesa RA. Managing myelofibrosis (MF) that “blasts” through: advancements in the treatment of relapsed/refractory and blast-phase MF. Hematology Am Soc Hematol Educ Program. 2018;2018:118-126.

Cited By

Email alerts

ASH Publications

American Society of Hematology

Scherber RM, Mesa RA. Managing myelofibrosis (MF) that “blasts” through: advancements in the treatment of relapsed/refractory and blast-phase MF. Hematology Am Soc Hematol Educ Program. 2018;2018:118-126.

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only